Drug intelligence / Profile preview

Chromifem

Development stage
Unknown
Lead developer
Merrell
Modality
Small Molecules
Administration
Oral
01

Overview

Chromifem is a multi-ingredient nutraceutical product developed by Rowez Life Sciences, primarily indicated for the management of Polycystic Ovary Syndrome (PCOS) and associated metabolic and hormonal imbalances. The formulation typically contains a combination of myo-inositol, D-chiro-inositol, chromium picolinate, and folic acid. These components work synergistically to improve insulin sensitivity, restore ovulatory function, and regulate the menstrual cycle. Myo-inositol and D-chiro-inositol act as second messengers in insulin signaling, facilitating glucose uptake and reducing hyperinsulinemia. Chromium picolinate enhances the activity of the insulin receptor tyrosine kinase, further improving insulin action. Folic acid is included to support reproductive health and manage homocysteine levels. Together, these ingredients help address the underlying insulin resistance and hormonal disruptions characteristic of PCOS.

Brand names
Chromifem
02

Targets

INSR (Insulin receptor)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on Chromifem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromifem.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call